000 | 01425 a2200433 4500 | ||
---|---|---|---|
005 | 20250513203900.0 | ||
264 | 0 | _c20000411 | |
008 | 200004s 0 0 eng d | ||
022 | _a0231-5882 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aManoach, M | |
245 | 0 | 0 |
_aThe role of sarcoplasmic reticulum in the protective effect of class III drugs against Ca2+ overload. _h[electronic resource] |
260 |
_bGeneral physiology and biophysics _cDec 1999 |
||
300 |
_a19-25 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnti-Arrhythmia Agents _xclassification |
650 | 0 | 4 |
_aArrhythmias, Cardiac _xetiology |
650 | 0 | 4 |
_aBridged Bicyclo Compounds, Heterocyclic _xpharmacology |
650 | 0 | 4 |
_aBucladesine _xpharmacology |
650 | 0 | 4 |
_aCalcium _xmetabolism |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 |
_aCyclopropanes _xpharmacology |
650 | 0 | 4 |
_aHeart _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIon Transport _xdrug effects |
650 | 0 | 4 |
_aMyocardium _xcytology |
650 | 0 | 4 | _aRats |
650 | 0 | 4 |
_aSarcoplasmic Reticulum _xdrug effects |
650 | 0 | 4 |
_aSotalol _xpharmacology |
650 | 0 | 4 |
_aThapsigargin _xpharmacology |
700 | 1 | _aVaron, D | |
700 | 1 | _aTribulova, N | |
700 | 1 | _aZinman, T | |
700 | 1 | _aKaplan, D | |
700 | 1 | _aKhananshvili, D | |
700 | 1 | _aShainberg, A | |
773 | 0 |
_tGeneral physiology and biophysics _gvol. 18 Suppl 1 _gp. 19-25 |
|
999 |
_c10661853 _d10661853 |